United States · FDA National Drug Code directory
Piperacillin and Tazobactam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-981_0802b499-4d2a-43ad-8fea-ad80b6738a46
- Product NDC
- 63323-981
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Piperacillin and Tazobactam
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180518
- Source listing expiry
- 20261231
Source-listed ingredients
- PIPERACILLIN SODIUM — 2 g/10mL
- TAZOBACTAM SODIUM — .25 g/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, SINGLE-USE in 1 CARTON (63323-981-21) / 10 mL in 1 VIAL, SINGLE-USE (63323-981-23) · 63323-981-21
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →